Enteritis is inflammation of the small intestine. The major cause of enteritis is contaminated food and water with bacteria or viruses. Bacterial agents like Escherichia coli, toxigenic Clostridium difficile, Campylobacter jejuni, and Vibrio cholerae are the major causes of infectious enteritis and disease is commonly known as bacteremia. These infectious agents then settle down in small intestine and cause swelling or inflammation. The major symptoms of infectious enteritis include fever, nausea, vomiting, diarrhoea etc. Among all the symptoms diarrhoea is highly prevalent. Disease conditions are most seen in under developed regions due to lack of awareness for personal hygiene and minimal healthcare expenditures. Initial infectious enteritis treatment may include fluid or electrolyte rehydration (ORS) and sometimes intravenous fluids. Ampicillin, Trimethoprim-sulfamethoxazole, Chloramphenicol, Tetracycline can be the first choice of antibacterial agents for infectious enteritis treatment. But with course of use these agents have developed resistance towards bacterial agents and hence probiotics can be the safest mode for infectious enteritis treatment. Lactobacillus reuteri, Lactobacillus rhamnosus, and the probiotic yeast Saccharomyces boulardiican help to treat diarrhoeal conditions in humans.
Infectious Enteritis Treatment Market: Drivers and Restraints
The rising population of diarrheal cases due to infectious enteritis especially in children is the major factor driving the growth of the infectious enteritis treatment market. According to WHO globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. These increasing prevalence of disease will help in driving the growth of infectious enteritis treatment market. The increasing application of drugs for the treatment of infectious enteritis such as Chloramphenicol and tetracycline are further expected to surge the growth of the infectious enteritis treatment market. Increasing FDA approvals of infectious enteritis treatment drugs are further expected to aid in the growth of the infectious enteritis treatment market. Intensive research and development activities to expand the therapeutic applications of infectious enteritis treatment drugs are further anticipated to support the growth of the infectious enteritis treatment market during the forecast years. The presence of a huge number of infectious enteritis treatment manufacturers is further boosting the growth of the infectious enteritis treatment market. However, there are several adverse effects associated with the treatment of infectious enteritis mainly resistance due to antibiotics, which in turn is hampering the growth of the infectious esophageal disorders treatment market. Lack of awareness among people in developing countries will also hamper the growth of infectious enteritis treatment market.
Infectious Enteritis Treatment Market: Overview
Infectious Enteritis Treatment Market is expected to have robust growth over the forecast period. On the basis of route of administration type, the infectious enteritis treatment market is majorly dominated by the oral segment as this is the first line of treatment for infectious enteric disease. Among the drug type segment, antibiotic segment is expected to dominate the infectious enteritis treatment market due to maximum availability of products. By end user, retail pharmacy is expected to dominate the infectious enteritis treatment market.
Infectious Enteritis Treatment Market: Key Players
The major in infectious enteritis treatment market are Abbott Laboratories, Baxter International, Pfizer, Bristol-Myers Squibb, Actelion Pharmaceuticals, Merck & Company, Lonza, BioGaia, ZBiotics company, Evolve Biosystems etc.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11251
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Indication
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-11251
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com